(Q43877187)

27 November 2017

Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients (English)

1 reference

27 November 2017

Marie Antignac

1

1 reference

27 November 2017

Christine Fernandez

2

1 reference

27 November 2017

Benoît Barrou

3

1 reference

27 November 2017

Mariona Roca

4

1 reference

27 November 2017

Jean-Louis Favrat

5

1 reference

27 November 2017

Saïk Urien

6

1 reference

27 November 2017

Robert Farinotti

7

1 reference

27 November 2017

24 February 2011

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

27 November 2017

1 reference

27 November 2017

36

1 reference

27 November 2017

1

1 reference

27 November 2017

25-33

1 reference

https://scigraph.springernature.com/pub.10.1007/s13318-011-0027-z

27 November 2017

0 references

cites work

Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics II: estimation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

First clinical experience with the new once-daily formulation of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Pharmacokinetics of tacrolimus in liver transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Some suggestions for measuring predictive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetics. A regulatory perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13318-011-0027-Z

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

21 January 2018

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations

1 reference

12 December 2020

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects

1 reference

12 December 2020

A whole blood FK 506 assay for the IMx analyzer

1 reference

12 December 2020

Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring.

1 reference

12 December 2020

Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.

1 reference

12 December 2020

Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients

1 reference

12 December 2020

10.1007/S13318-011-0027-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference